The chemical structure of oligonucleotide analogues dictates the conformation of oligonucleotide analogue oligomers, their ability to hybridize complementary DNA and RNA, their stability to degradation and their pharmacokinetic properties. In a study aimed at investigating new analogues featuring a neutral backbone, we explored the ability of oligomers containing a morpholino-peptide backbone to bind oligonucleotides. Circular Dichroism studies revealed the ability of our oligomers to interact with DNA, molecular modelling studies revealed the interaction responsible for complex stabilization.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.bbrc.2021.02.087 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!